Abstract:CD4(+) T cells play critical roles in orchestrating adaptive immune responses. Their activation and proliferation are critical steps that occur before they execute their biological functions. Despite the important role of this process, the underlying molecular events are not fully understood. MicroRNAs (miRNAs) have been shown to play important roles in lymphocyte development and function. However, the miRNAs that regulate T-cell differentiation, activation and proliferation are still largely unknown. In our previous study, using a miRNA array, we found that several miRNAs (including miR-202, 33b, 181c, 568 and 576) are differentially expressed between resting and activated CD4(+) T cells. In this study, we focused on the function of miR-568 during CD4(+) T-cell activation. We showed that the expression level of miR-568 decreased during the activation of T cells, including Jurkat cells and human peripheral blood CD4(+) T cells. When Jurkat or human peripheral blood CD4(+) T cells were transfected with miR-568 mimics, cell activation was significantly inhibited, as shown by the inhibited expression of activation markers such as CD25, CD69 and CD154; decreased IL-2 production; and inhibited cell proliferation. Using software predictions and confirmatory experiments, we demonstrated that nuclear factor of activated T cells 5 (NFAT5) is a target of miR-568. Treg cells are an important CD4(+) T-cell subpopulation, so we also evaluated the function of miR-568 in Treg-cell activation and differentiation. We showed that the miR-568 level decreased, while the NFAT5 protein level increased during CD4(+)CD25(+) Treg-cell activation, and the transfection of miR-568 mimics inhibited the NFAT5 expression, inhibited the production of both TGF-β and IL-10 and also inhibited the proliferation of Treg cells. Our further study showed that over-expression of miR-568 can inhibit Treg-cell differentiation and can inhibit the suppressive effect of these cells on effector cells. In addition, inhibition of NFAT5 by siRNA-mediated knockdown can inhibit the activation and differentiation of Treg cells. These findings reveal that miR-568 can inhibit the activation and function of both CD4(+) T cells and Treg cells by targeting NFAT5. Since miR-568 plays an important role in both CD4(+) T cells and Treg cells, these findings may provide leads for the development of novel treatments for human inflammatory and autoimmune diseases.

Mir-9 Enhances the Transactivation of Nuclear Factor of Activated T Cells by Targeting KPNB1 and DYRK1B.

Identification of Resting and Type I Ifn-Activated Human Nk Cell Mirnomes Reveals Microrna-378 and Microrna-30e As Negative Regulators of Nk Cell Cytotoxicity

Mir-16 Targets Transcriptional Corepressor SMRT and Modulates NF-kappaB-regulated Transactivation of Interleukin-8 Gene.

Cellular Micrornas Up-Regulate Transcription Via Interaction with Promoter TATA-box Motifs

MiR-9 Promotes Microglial Activation by Targeting MCPIP1

Target Regulation of Mir-9 to the Expression of NRP1 and Its Role in Radiation Effects

Mir-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis.

A Mir-19 Regulon That Controls NF-κB Signaling

Microrna-9 Regulates The Differentiation And Function Of Myeloid-Derived Suppressor Cells Via Targeting Runx1

Regulation of T Lymphocyte Activation by Microrna-21.

[Mir-338-5p Modulates B Cell Biological Functions by Targeting NF-κB1].

A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer

Mir-31 Regulates Interleukin 2 and Kinase Suppressor of Ras 2 During T Cell Activation

MiR-568 Inhibits the Activation and Function of CD4⁺ T Cells and Treg Cells by Targeting NFAT5.

miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1

The Regulation Of Nfat Pathway By Micrornas

Mir-892b Silencing Activates Nf-Kappa B And Promotes Aggressiveness In Breast Cancer

Mir-486 Sustains Nf-Kappa B Activity By Disrupting Multiple Nf-Kappa B-Negative Feedback Loops

Mir-96 Promotes Cell Proliferation, Migration and Invasion by Targeting PTPN9 in Breast Cancer.

Mir-99A Regulates CD4+ T Cell Differentiation and Attenuates Experimental Autoimmune Encephalomyelitis by Mtor-Mediated Glycolysis.

Mir-149-3p Reverses Cd8(+) T-Cell Exhaustion By Reducing Inhibitory Receptors And Promoting Cytokine Secretion In Breast Cancer Cells